Effectiveness of Amisulpride in Treating Bipolar I Disorder
Author Information
Author(s): Mauro Giovanni Carta, Fausta Zairo, Gisa Mellino, Maria Carolina Hardoy, Eduard Vieta
Primary Institution: Department of Public Health, University of Cagliari, Italy
Hypothesis
Can amisulpride improve long-term outcomes in patients with bipolar I disorder who are not responding to standard therapies?
Conclusion
Long-term therapy with amisulpride may reduce relapse rates and improve symptoms in patients with bipolar I disorder.
Supporting Evidence
- Patients showed a statistically significant decrease in overall relapse rates during amisulpride therapy.
- The relative risk of relapse without amisulpride was 3.1.
- Manic relapse rates decreased significantly during amisulpride therapy.
Takeaway
This study found that adding amisulpride to treatment helped people with bipolar disorder feel better and have fewer episodes of mania.
Methodology
The study followed 14 bipolar I outpatients, assessing relapse rates before and after adding amisulpride to their treatment.
Potential Biases
The open-label design may introduce assessment bias.
Limitations
The study had a small sample size and lacked a control group.
Participant Demographics
8 men and 6 women, average age 42.3 years.
Statistical Information
P-Value
P < 0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website